Mark Sadaka travelled to Santa Fe, New Mexico to argue before the Judicial Panel on Multidistrict Litigation for the 1000s of people injured by Zostavax, a vaccine given to adults to prevent shingles. Because there are so many cases, Merck asked for all of the cases to be heard in front of one court. Sadaka Associates argued that the case should be consolidated in Philadephia before Judge Bartle of the Eastern District of Pennsylvania.
Zostavax may cause meningitis, encephalitis, stroke, and other brain injuries. Since 2011, Sadaka Associates has filed many shingles lawsuits on behalf of those seriously injured by Zostavax. Merck’s Zostavax is the only FDA approved vaccine for the prevention of shingles that contains live-virus. Shingles is caused by the chickenpox virus, varicella zoster.
Since Zostavax contains live virus the vaccine can cause the disease it was meant prevent.
The virus contained in Zostavax can cause chickenpox and shingles (herpes zoster). Chickenpox and shingles can cause serious damage to the nervous system including meningitis, encephalitis, acute disseminated encephalomyelitis (ADEM), and stroke.